Link Found Between Behavioral Stress and Vaccine Effectiveness

Researchers at Tel Aviv University have found a significant connection between behavioral stress and the efficacy of vaccines. Their study, conducted on mice, revealed that acute stress experienced 9-12 days after vaccination resulted in a 70% increase in antibody response to the vaccine. However, this enhanced response came at the cost of reduced antibody breadth, leading to decreased protection against variants of the targeted pathogen.

The study, published in Brain, Behavior, and Immunity, investigated the impact of acute stress on the immune response following vaccination. The researchers administered two different vaccines to the mice and induced stress using a widely used behavioral paradigm. Surprisingly, mice exposed to stress exhibited a significantly stronger immune response, with higher levels of antibodies in their blood and B cells.

Further investigation showed that stress caused the immune system to focus solely on the original vaccine, neglecting to respond to variants of the protein used in the vaccine, including variants of concern of SARS-CoV-2. The enhancement of antibody activity following stress was linked to the activation of the beta2 adrenergic receptor, which identifies adrenaline. Blocking this receptor eliminated the effects of stress on the immune response.

The researchers also conducted a study on B cells from humans who had previously contracted COVID-19. Similar to the findings in mice, human B cells exhibited a trade-off between the intensity and breadth of the immune response under stress. Activation of the beta2 adrenergic receptor in human cells led to a stronger antibody response but reduced antibody diversity.

According to senior author Natalia Freund, this stress-induced immune response resembles the "fight or flight" response observed at the molecular level. During stress, the immune system prioritizes addressing the immediate infection, producing large quantities of stronger antibodies. However, this investment in the present weakens the creation of long-lasting immunological memory, crucial for protection against future pathogen mutations.